According to the Complaint, GEO Group is purportedly the first fully integrated equity real estate investment trust specializing in the design, financing, development, and operation of secure facilities, processing centers, and community reentry centers in the U.S., Australia, South Africa, and the United Kingdom. GEO Group is also purportedly a leading provider of enhanced in-custody rehabilitation, post-release support, electronic monitoring, and community-based programs. The Company's worldwide operation include the ownership and/or management of, among other facilities, halfway houses in the U.S.
According to the Complaint, China XD Plastics Company Limited engages in the research, development, manufacture, and sale of modified plastics primarily for automotive applications in the People’s Republic of China, and Dubai, the United Arab Emirates.
According to the Complaint, Pilgrim’s Pride Corporation is a large, vertically integrated producer of meat products. The majority of Pilgrim’s Pride’s annual sales arise from chicken products, which the Company primarily sells to grocers and chain restaurants.
According to the Complaint, Chembio Diagnostics, Inc. describes itself as "a leading provider of point-of-care diagnostic products for the detection and diagnosis of infectious diseases."
According to the Complaint, Kingold purports to design, manufacture, and sell 24-karat gold jewelry and Chinese ornaments in the People's Republic of China.
According to the Complaint, Finjan Holdings, Inc. is a cybersecurity company, provides intellectual property licensing and enforcement services in the United States and internationally.
According to the Complaint, Kirkland is a Canadian limited liability company headquartered in Toronto, Ontario. Kirkland owns and operates gold mines in Canada and Australia.
According to the Complaint, Ideanomics purports to be a global company focused on facilitating the adoption of commercial electric vehicles and developing next generation financial services and Fintech products.
According to the Complaint, resTORbio, Inc. is a clinical-stage biopharmaceutical company that develops innovative medicines that target the biology of aging to treat aging-related diseases.
According to the Complaint, Mylan N.V. is the second largest generic drug manufacturer in the world with roughly 55 manufacturing and R&D facilities globally. Mylan’s largest U.S. manufacturing facility is located in Morgantown, West Virginia. At the start of the Class Period, the facility manufactured approximately 17 billion doses of medication every year, comprising 85% of all medicine Mylan sold in the United States in 2016.